Impact of the new 5-HT3 receptor antagonist palonosetron (P) in chemotherapy-induced nausea and vomiting (CINV) control in elderly advanced breast cancer (EABC) patients: Comparison with the classic antiemetic agent ondansetron (O).

Giuseppe Bronte; Ignazio Carreca; Fernanda Manuela Bellomo

Impact of the new 5-HT3 receptor antagonist palonosetron (P) in chemotherapy-induced nausea and vomiting (CINV) control in elderly advanced breast cancer (EABC) patients: Comparison with the classic antiemetic agent ondansetron (O).

Giuseppe Bronte, Ignazio Carreca, Fernanda Manuela Bellomo

Risultato della ricerca: Other

Lingua originale	English
Pagine	158-158
Stato di pubblicazione	Published - 2007

Altri file e collegamenti

OA Link

Cita questo

@conference{7ec5029a797a4111b78327190bfa024e,

title = "Impact of the new 5-HT3 receptor antagonist palonosetron (P) in chemotherapy-induced nausea and vomiting (CINV) control in elderly advanced breast cancer (EABC) patients: Comparison with the classic antiemetic agent ondansetron (O).",

author = "Giuseppe Bronte and Ignazio Carreca and Bellomo, {Fernanda Manuela}",

year = "2007",

language = "English",

pages = "158--158",

}

TY - CONF

T1 - Impact of the new 5-HT3 receptor antagonist palonosetron (P) in chemotherapy-induced nausea and vomiting (CINV) control in elderly advanced breast cancer (EABC) patients: Comparison with the classic antiemetic agent ondansetron (O).

AU - Bronte, Giuseppe

AU - Carreca, Ignazio

AU - Bellomo, Fernanda Manuela

PY - 2007

Y1 - 2007

UR - http://hdl.handle.net/10447/12483

M3 - Other

SP - 158

EP - 158

ER -